Revvity (NYSE:RVTY) Hits New 12-Month High – What’s Next?

Revvity Inc. (NYSE:RVTY) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $118.34 and last traded at $117.8960, with a volume of 46220 shares changing hands. The stock had previously closed at $117.88.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Barclays lifted their price target on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Wall Street Zen upgraded Revvity from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th. TD Cowen reaffirmed a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Finally, Wolfe Research started coverage on shares of Revvity in a research report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Three analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat, Revvity presently has an average rating of “Hold” and a consensus price target of $108.36.

Revvity Stock Down 0.7%

The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The stock has a market capitalization of $13.02 billion, a P/E ratio of 55.58, a PEG ratio of 2.14 and a beta of 1.07. The stock’s fifty day moving average is $109.62 and its two-hundred day moving average is $100.09.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. The company had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm’s revenue was down 1.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, research analysts predict that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s payout ratio is 13.33%.

Hedge Funds Weigh In On Revvity

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. New Mexico Educational Retirement Board increased its stake in Revvity by 1.9% in the 4th quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after purchasing an additional 100 shares in the last quarter. Allworth Financial LP lifted its stake in Revvity by 8.9% during the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after buying an additional 104 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Revvity by 17.0% during the first quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock valued at $66,000 after buying an additional 109 shares in the last quarter. HighTower Advisors LLC boosted its holdings in shares of Revvity by 2.6% in the fourth quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock worth $497,000 after buying an additional 129 shares during the period. Finally, Cary Street Partners Financial LLC boosted its holdings in shares of Revvity by 1.6% in the fourth quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock worth $865,000 after buying an additional 141 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.